Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-21 Purchase |
2020-07-21 7:35 pm |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
14,000 | $18 | $252,000 | 1,065,256 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:33 pm |
Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer |
2,000 | $18 | $36,000 | 261,246 (Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:33 pm |
Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director |
1,000 | $18 | $18,000 | 91,738 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:32 pm |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
1,200 | $18 | $21,600 | 619,330 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:29 pm |
Pandion Therapeutics Inc. | PAND | Frail Donald Director |
10,000 | $18 | $180,000 | 79,860 (Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:28 pm |
Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance |
600 | $18 | $10,800 | 49,625 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-07-17 Option Award |
2020-07-21 7:37 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Carlo Rizzuto Director |
13,997 | $0 | 13,997 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:35 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
348,741 | $0 | 1,065,256 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:35 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
128,901 | $0 | 1,065,256 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:33 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer |
145,420 | $0 | 261,246 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:33 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director |
17,671 | $0 | 91,738 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:33 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director |
91,522 | $0 | 91,738 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:32 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
114,876 | $0 | 619,330 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:32 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
128,901 | $0 | 619,330 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:29 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Frail Donald Director |
18,747 | $0 | 79,860 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:29 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Frail Donald Director |
71,613 | $0 | 79,860 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:28 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance |
27,500 | $0 | 49,625 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:28 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer |
55,903 | $0 | 110,364 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:28 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer |
14,322 | $0 | 110,364 (Direct) |
View |
Ownership |
2020-07-16 9:57 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Access Industries Holdings LLC AI Pan LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 1,878,551 (Indirect) |
View |
Ownership |
2020-07-16 9:52 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner |
0 | $0 | 1,887,193 (Indirect) |
View |
Ownership |
2020-07-16 8:51 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 1,408,912 (Indirect) |
View |
Ownership |
2020-07-16 8:40 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC 10% Owner |
0 | $0 | 657,492 (Indirect) |
View |
Ownership |
2020-07-16 8:38 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
0 | $0 | 3,754,051 (Direct) |
View |
Ownership |
2020-07-16 8:38 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
0 | $0 | 86,314 (Direct) |
View |
Ownership |
2020-07-16 8:36 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner |
0 | $0 | 3,165,311 (Indirect) |
View |
Ownership |
2020-07-16 8:36 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
0 | $0 | 3,049,973 (Indirect) |
View |
Ownership |
2020-07-16 8:33 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
0 | $0 | 702,515 (Indirect) |
View |
Ownership |
2020-07-16 8:29 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. 10% Owner |
0 | $0 | 1,408,913 (Direct) |
View |
Ownership |
2020-07-16 8:27 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner |
0 | $0 | 3,049,973 (Indirect) |
View |
Ownership |
2020-07-16 8:27 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director |
0 | $0 | 73,067 (Indirect) |
View |
Ownership |
2020-07-16 8:22 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner |
0 | $0 | 1,887,193 (Indirect) |
View |
Ownership |
2020-07-16 8:21 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer |
0 | $0 | 113,826 (Direct) |
View |
Ownership |
2020-07-16 8:21 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | BELOFF GREGG See Remarks |
0 | $0 | 13,196 (Indirect) |
View |
Ownership |
2020-07-16 8:19 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner |
0 | $0 | 426,333 (Direct) |
View |
Ownership |
2020-07-16 8:18 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Frail Donald Director |
0 | $0 | 51,113 (Direct) |
View |
Ownership |
2020-07-16 8:18 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
0 | $0 | 503,254 (Direct) |
View |
Ownership |
2020-07-16 8:17 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance |
0 | $0 | 21,525 (Direct) |
View |
Ownership |
2020-07-16 8:16 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
0 | $0 | 1,878,551 (Indirect) |
View |
Ownership |
2020-07-16 8:14 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer |
0 | $0 | 54,461 (Direct) |
View |
Ownership |
2020-07-16 8:14 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner |
0 | $0 | 1,408,913 (Indirect) |
View |
Ownership |
2020-07-16 8:14 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner |
0 | $0 | 3,571,783 (Direct) |
View |